Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate
Therapeutic Area : Dermatology
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
New Study Reveals Bioiberica's Dermial® Delivers Superior Benefits for Skin Health
Details : New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.
Product Name : Dermial
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 25, 2022
Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate
Therapeutic Area : Dermatology
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : KMN-159,Collagen
Therapeutic Area : Musculoskeletal
Study Phase : Preclinical
Sponsor : NIDCR
Deal Size : $1.7 million
Deal Type : Funding
Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
Details : The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
September 16, 2021
Lead Product(s) : KMN-159,Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Sponsor : NIDCR
Deal Size : $1.7 million
Deal Type : Funding
Lead Product(s) : Collagen
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Chia Nan University of Pharmacy and Science
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Skin-Beautifying Effects of Collagen Drinks
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
March 28, 2025
Lead Product(s) : Collagen
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Chia Nan University of Pharmacy and Science
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagen
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effectiveness of Hydrolyzed Collagen Peptide Injection for the Treatment of Collateral Ligament Pain
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
August 02, 2023
Lead Product(s) : Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagen
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Tessenderlo Chemie NV
Deal Size : Inapplicable
Deal Type : Inapplicable
Collagen Peptide Supplementation and Lifelong Athletes
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
March 02, 2023
Lead Product(s) : Collagen
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Tessenderlo Chemie NV
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagen
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Collagen Lifesciences Private Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
November 14, 2022
Lead Product(s) : Collagen
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Collagen Lifesciences Private Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagen
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigation of the Bioavailability of Marine Based Collagen Peptides in Healthy Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
February 23, 2022
Lead Product(s) : Collagen
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagen
Therapeutic Area : Sleep
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy Testing of Collagen Drink on Skin Beauty and Sleep Aid
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
January 10, 2022
Lead Product(s) : Collagen
Therapeutic Area : Sleep
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagen
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy Testing of Collagen Peptide Drink
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
August 09, 2021
Lead Product(s) : Collagen
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagen
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Tosla d.o.o. | Slovenian Research Agency
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
August 03, 2021
Lead Product(s) : Collagen
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Tosla d.o.o. | Slovenian Research Agency
Deal Size : Inapplicable
Deal Type : Inapplicable